BCAS2 anticorps (AA 1-225)

N° du produit ABIN6137479

Détail du produit anti-BCAS2 anticorps

Antigène: BCAS2 (Breast Carcinoma Amplified Sequence 2 (BCAS2))

Épitope: AA 1-225

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp BCAS2 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF)

Séquence: MAGTGLVAGE VVVDALPYFD QGYEAPGVRE AAAALVEEET RRYRPTKNYL SYLTAPDYSA FETDIMRNEF ERLAARQPIE LLSMKRYELP APSSGQKNDI TAWQECVNNS MAQLEHQAVR IENLELMSQH GCNAWKVYNE NLVHMIEHAQ KELQKLRKHI QDLNWQRKNM QLTAGSKLRE MESNWVSLVS KNYEIERTIV QLENEIYQIK QQHGEANKEN IRQDF

Réactivité croisée: Humain, Souris, Rat

Attributs du produit: Polyclonal Antibodies

Purification: Affinity purification

Immunogène: Recombinant fusion protein containing a sequence corresponding to amino acids 1-225 of human BCAS2 (NP_005863.1).

Isotype: IgG

Information d'application

Indications d'application: WB,1:500 - 1:2000,IHC,1:50 - 1:200,IF,1:50 - 1:200

Commentaires:

HIGH QUALITY

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Avoid freeze / thaw cycles.

Détails sur BCAS2

Antigène: BCAS2 (Breast Carcinoma Amplified Sequence 2 (BCAS2))

Autre désignation: BCAS2 (BCAS2 Produits)

Synonymes: anticorps DAM1, anticorps SPF27, anticorps Snt309, anticorps 6430539P16Rik, anticorps AI132645, anticorps C76366, anticorps C80030, anticorps BCAS2, anticorps cb302, anticorps zgc:101730, anticorps BCAS2, pre-mRNA processing factor, anticorps breast carcinoma amplified sequence 2, anticorps breast carcinoma amplified sequence 2 L homeolog, anticorps BCAS2, anticorps Bcas2, anticorps bcas2, anticorps bcas2.L, anticorps CpipJ_CPIJ003889

Sujet: Required for pre-mRNA splicing as component of the activated spliceosome. Component of the PRP19-CDC5L complex that forms an integral part of the spliceosome and is required for activating pre-mRNA splicing. May have a scaffolding role in the spliceosome assembly as it contacts all other components of the core complex. The PRP19-CDC5L complex may also play a role in the response to DNA damage (DDR.,BCAS2,DAM1,SPF27,Snt309,Epigenetics & Nuclear Signaling,BCAS2

Poids moléculaire: 26 kDa

ID gène: 10286

UniProt: O75934